CVS HealthCVSEarnings & Financial Report
CVS Health Corporation is an American multinational healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. The company is the world's second largest healthcare company, behind UnitedHealth Group. In 2023, the company was ranked 64th in the Forbes Global 2000. CVS started in Lowell, Massachusetts by brothers Stanley and Sidney Goldstein and their partner Ralph Hoagland.
CVS Q4 2025 Key Financial Metrics
売上高
$105.7B
粗利益
$46.6B
営業利益
$2.1B
純利益
$2.9B
粗利益率
44.1%
営業利益率
2.0%
純利益率
2.8%
前年比成長
8.2%
EPS
$2.31
資金フロー
CVS Health Q4 2025 Financial Summary
CVS Health reported revenue of $105.7B for Q4 2025, with a net profit of $2.9B (2.8% margin). Cost of goods sold was $59.1B, operating expenses totaled $44.5B.
Key Financial Metrics
| Total Revenue | $105.7B |
|---|---|
| Net Profit | $2.9B |
| Gross Margin | 44.1% |
| Operating Margin | 2.0% |
| Report Period | Q4 2025 |
CVS Health Annual Revenue by Year
CVS Health annual revenue history includes year-by-year totals (for example, 2025 revenue was $402.1B).
| Year | Annual Revenue |
|---|---|
| 2025 | $402.1B |
| 2024 | $372.8B |
| 2023 | $357.8B |
| 2022 | $322.5B |
損益計算書
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $88.44B | $91.23B | $95.43B | $97.71B | $94.59B | $98.92B | $102.87B | $105.69B |
| 前年比成長 | 3.7% | 2.6% | 6.3% | 4.2% | 7.0% | 8.4% | 7.8% | 8.2% |
貸借対照表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $249.74B | $252.48B | $252.43B | $253.22B | $255.59B | $258.34B | $255.33B | $253.54B |
| 総負債 | $175.59B | $177.37B | $177.32B | $177.49B | $178.47B | $180.79B | $182.22B | $178.16B |
| 株主資本 | $73.97B | $74.93B | $74.94B | $75.56B | $76.93B | $77.38B | $72.93B | $75.21B |
キャッシュフロー
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 営業CF | $4.90B | $3.09B | $-745.0M | $1.86B | $4.56B | $1.90B | $796.0M | $3.39B |
Other Health Care Companies
CI
Cigna
売上高
$69.7B
純利益
N/A
DVA
DaVita
売上高
$3.6B
純利益
$234.2M
LH
Labcorp
売上高
$3.6B
純利益
$261.1M
DGX
Quest Diagnostics
売上高
$2.8B
純利益
$245.0M
ABT
Abbott Laboratories
売上高
$11.4B
純利益
$1.6B
ABBV
AbbVie
売上高
$15.8B
純利益
$186.0M
A
Agilent Technologies
売上高
$1.9B
純利益
$434.0M
ALGN
Align Technology
売上高
$995.7M
純利益
$56.8M
AMGN
Amgen
売上高
$9.9B
純利益
$1.3B
BAX
Baxter International
売上高
$3.0B
純利益
$-1.1B